The assessment of efficacy of oral 1,25 (OH) D (Calcitriol) in psoriasis PSORIASISTE ORAL 1.25(OH) D (KALSITRIOL)'UN ETKINLIGININ DEGERLENDIRILMESI
Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.29, sa.2, ss.97-100, 1995 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 2
- Basım Tarihi: 1995
- Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.97-100
- Anahtar Kelimeler: Calcitriol, Psoriasis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background and design. - 1,25(OH) 2D3 which is active form of vitamin D, was used in 14 patients by orally 0.25 microg/g/day for 1 month to determine its efficacy in psoriasis. On each patient a target lesion, which had the most bad appearance, was elected for the follow-up, and erythema, scaling and infiltration were scored from 0 to 3 on it. The improvements rates were indicated by assessing total scores before and after treatment. Results. - The lowest rate was 25 %, the highest one 67 %, and the total response rate was 86 %. Conclusion. - It has been thought that improvement rates were dose-dependent and with regard to this 0.25 microg/g/day was not very effective dose and 0.50 microg/g/day - higher doses should be tried with placebo controls for longer times.